posted on
Apr 19, 2007 01:28PM
Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Re: Mr. Pohl / ptscman, the Q reports warrant conversion
Apr 19, 2007 09:40AM
Apr 19, 2007 09:59AM
Apr 19, 2007 10:00AM
and, while late, the Q reports are published. Were / Are you looking for a more formal discussion of the S & L deal?
If so, then I'm not sure what management could have done or do. As many have complained, they have choosen to let S & L play out their warrants. One of the mysteries mentioned by several here is WHY S&L converts and sells now, at this price. My guess (WAG) would be to diversify their total holdings. S&L has zero responsibility to PTSC's sharholders and they may want to convert all of the warrants prior to the Markman results being known.
Again, just my guess, but I would like to see another reduction in the warrants held on the coming Q report next week (in theory).
John
Loading...
Loading...
New Message
Please
login
to post a reply